SUIT CLAIMS FORMER FDA CHIEF HELPED HUBBY’S HEDGE FUND MAKE MILLIONS: Katie Watson of the Daily Caller News Foundation Investigative Group reports that former FDA Commissioner Margaret Hamburg is accused in a suit filed in federal court of using her office to clear the way to approval for Levaquin, a controversial antibiotic in which her husband’s hedge fund just happened to be highly invested.
“Once confirmed as FDA commissioner, Dr. Margaret A. Hamburg acted as the instrumentality that all defendants used to perpetrate their conspiracy and racketeering enterprise by having her act illegally and outside the scope of her authority as FDA commissioner to suppress material information to plaintiffs and the public that Levaquin was inherently dangerous and in fact, deadly,” the complaint alleges, according to Watson.
Alexandra Walsh, an attorney for Hamburg, strongly disputed the suit’s claims, saying “Mr. Klayman’s allegations against Dr. Hamburg are patently false. There is no factual or legal basis for the lawsuit he has filed, and we are confident the court will dismiss his claims in their entirety.” Walsh was referring to Larry Klayman, attorney for the six plaintiffs in the case.
Hamburg was appointed by President Obama in 2009 and served until March 2015.